Is COX-2 inhibition a panacea for cancer prevention?
Author:
Open Access
- 30 October 2001
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 94 (5) , 613-614
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- New paradigms for cancer prevention.Carcinogenesis, 2001
- Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic MiceJournal of Biological Chemistry, 2001
- Combinatorial chemoprevention of intestinal neoplasiaNature Medicine, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and CarcinogenesisAnnals of the New York Academy of Sciences, 1999
- Effect of α-Difluoromethylornithine on Rectal Mucosal Levels of Polyamines in a Randomized, Double-Blinded Trial for Colon Cancer PreventionJNCI: Journal of the National Cancer Institute, 1998
- Barrettʼs oesophagus, oesophageal cancer and colon cancer: an explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugsEuropean Journal Of Cancer Prevention, 1998
- Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health StudyAnnals of Internal Medicine, 1998
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995
- Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouseCell, 1995